Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia [Phase 3]
Phase 3 randomized, open-label study comparing guadecitabine versus treatment choice in previously treated acute myeloid leukemia has comple…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating combinations including OX40, venetoclax, avelumab, glasdegib, gemtuzumab ozogamicin, and azacitidine in …
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia [Phase 2]
A Phase 2 trial studying temsirolimus added to standard chemotherapy in patients over 60 with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease [Phase 2]
Phase 2 clinical trial investigating salsalate, venetoclax, and decitabine or azacitidine for acute myeloid leukemia and advanced myelodyspl…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 1, Phase 2]
Clinical trial update for IMM01 combined with azacitidine in acute myeloid leukemia and myelodysplastic syndromes, currently in Phase 1 and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy [Phase 2, Phase 3]
Clinical trial updates on an antifungal showing safety, efficacy, and pharmacokinetics in patients undergoing chemotherapy (Phase 2/Phase 3)…
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating treatments to improve outcomes for adults with acute myeloid leukemia and high-risk myelodysplastic sy…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia [Phase 2]
Phase 2 clinical trial evaluating low-dose daunorubicin in pediatric relapsed/refractory acute leukemia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Reduced Intensity Conditioning Transplant Using Haploidentical Donors [Phase 2]
Phase 2 clinical trial investigating reduced intensity conditioning transplant using haploidentical donors for various hematologic malignanc…
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Guadecitabine Extension Study [Phase 2]
Phase 2 extension study of guadecitabine in acute myeloid leukemia and myelodysplastic syndrome was terminated; results were posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT [Phase 2]
A Phase 2 clinical trial evaluating a conditioning regimen combining venetoclax, azacytidine, and a modified BUCY approach for patients with…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and efficacy of a CD123-targeted CAR-T therapy for relapsed/refractory acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: MG4101 for Refractory or Relapsed AML [Phase 2]
Phase 2 clinical trial update for MG4101 in refractory or relapsed acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial update on a CD123-targeted CAR-T cell therapy for relapsed/refractory acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies [Phase 1]
Phase 1 trial updating safety, tolerability, pharmacokinetics, and efficacy of AMG 397 in relapsed or refractory hematological malignancies;…
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Venetoclax Combined With Azacitidine and CAG in Refractory/Relapse Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating venetoclax with azacitidine and CAG regimen in refractory/relapsed acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 study evaluating intensity-modulated radiation therapy with etoposide and cyclophosphamide followed by donor stem cell transplan…
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML [Phase 2, Phase 3]
Phase 2/3 trial evaluating venetoclax with homoharringtonine and cytarabine for induction in acute myeloid leukemia, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia [Phase 2]
Phase 2 trial evaluating Clofarabine plus Melphalan as a conditioning regimen before donor stem cell transplantation for patients with myelo…
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML [Phase 1, Phase 2]
A Phase I/II dose-escalation and expansion study evaluating BST-236 combined with venetoclax in adults with unfit newly diagnosed acute myel…
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With Bortezomib [Phase 2]
Phase 2 clinical trial update evaluating bortezomib to overcome epigenetic therapy resistance in acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation [Phase 3]
This clinical trial update reports results from a Phase 3 study of ivosidenib combined with azacitidine versus placebo in previously untreat…
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation [Phase 3]
Phase 3 trial evaluating AG-120 (ivosidenib) plus azacitidine vs placebo in previously untreated IDH1-mutated acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R [Phase 2]
Phase 2 trial evaluating autologous bone marrow transplantation using a preparative regimen of busulfan/fractionated total body irradiation …
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy [Phase 3]
Phase 3 trial evaluating venetoclax with azacitidine or decitabine in outpatient AML patients ineligible for intensive chemotherapy has comp…